Wolverine Trading, LLC Cor Medix Inc. Put Options Transaction History

Wolverine Trading, LLC

$103 Billion
Q4 2024

Put Options

21 transactions

Quarter	Operation	Price Per put	puts change	puts Held	SEC Form
Quarter	Operation	Price Per put	puts change	puts Held	SEC Form
Q4 2024 Feb 14, 2025	BUY	$8.1 - $13.59 $55,890 - $93,771	6,900 Added 46.94%	21,600 $174,000
Q3 2024 Nov 14, 2024	BUY	$3.64 - $8.23 $6,552 - $14,814	1,800 Added 13.95%	14,700 $118,000
Q2 2024 Aug 14, 2024	SELL	$4.08 - $6.39 $24,072 - $37,701	-5,900 Reduced 31.38%	12,900 $55,000
Q1 2024 May 15, 2024	BUY	$2.94 - $4.24 $13,818 - $19,928	4,700 Added 33.33%	18,800 $79,000
Q4 2023 Feb 14, 2024	BUY	$3.0 - $4.01 $42,300 - $56,541	14,100 New	14,100 $53,000
Q2 2023 Aug 23, 2023	SELL	$3.94 - $5.8 $12,214 - $17,980	-3,100 Reduced 21.53%	11,300 $44,000
Q1 2023 May 15, 2023	SELL	$3.22 - $4.61 $23,506 - $33,653	-7,300 Reduced 33.64%	14,400 $60,000
Q4 2022 Feb 14, 2023	SELL	$2.81 - $4.45 $30,348 - $48,060	-10,800 Reduced 33.23%	21,700 $92,000
Q3 2022 Nov 14, 2022	BUY	$2.82 - $7.52 $56,964 - $151,904	20,200 Added 164.23%	32,500 $92,000
Q2 2022 Aug 15, 2022	SELL	$2.73 - $5.61 $6,006 - $12,342	-2,200 Reduced 15.17%	12,300 $44,000
Q4 2021 Feb 14, 2022	SELL	$4.47 - $5.56 $44,700 - $55,599	-10,000 Reduced 40.82%	14,500 $68,000
Q3 2021 Nov 12, 2021	BUY	$4.46 - $7.11 $39,694 - $63,279	8,900 Added 57.05%	24,500 $114,000
Q2 2021 Aug 06, 2021	BUY	$6.05 - $10.09 $17,545 - $29,261	2,900 Added 22.83%	15,600 $112,000
Q4 2020 Feb 12, 2021	BUY	$5.0 - $9.15 $13,500 - $24,705	2,700 Added 27.0%	12,700 $94,000
Q3 2020 Nov 13, 2020	SELL	$3.96 - $6.15 $21,384 - $33,210	-5,400 Reduced 35.06%	10,000 $59,000
Q2 2020 Aug 13, 2020	BUY	$3.08 - $6.56 $12,012 - $25,584	3,900 Added 33.91%	15,400 $95,000
Q1 2020 May 11, 2020	SELL	$2.35 - $7.08 $80,135 - $241,428	-34,100 Reduced 74.78%	11,500 $41,000
Q4 2019 Feb 12, 2020	BUY	$4.96 - $7.75 $226,176 - $353,400	45,600 New	45,600 $313,000
Q3 2019 Nov 14, 2019	SELL	$6.38 - $9.69 $121,220 - $184,110	-19,000 Closed	0 $0
Q2 2019 Aug 20, 2019	SELL	$5.93 - $10.57 $17,197 - $30,653	-2,900 Reduced 13.24%	19,000 $170,000
Q1 2019 May 15, 2019	BUY	$6.95 - $13.25 $152,205 - $290,175	21,900 New	21,900 $207,000

Others Institutions Holding CRMD

# of Institutions

135

Shares Held

21.9M

Call Options Held

599K

Put Options Held

401K

Black Rock Inc. New York, NY

3.55M
Shares

$33.4 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

3.38M
Shares

$31.8 Million
0.0% of portfolio
Paul Singer Elliott Investment Management L.P. | West Palm Beach, Fl

2.87M
Shares

$27 Million
0.14% of portfolio
State Street Corp Boston, MA

1.45M
Shares

$13.7 Million
0.0% of portfolio
Geode Capital Management, LLC Boston, MA

1.39M
Shares

$13.1 Million
0.0% of portfolio

View Full List

About CorMedix Inc.

Ticker CRMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,208,200
Market Cap $387M
Description
CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath/Neutrolin, a novel anti-infective solution for the reduction and prevention of cathet...

More about CRMD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.

Account